Credit Suisse Downgrades Genesis Healthcare (GEN) to Underperform
Tweet Send to a Friend
Credit Suisse analyst A.J. Rice downgraded Genesis Healthcare (NYSE: GEN) from Neutral to Underperform with a price target of $0.57.The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
